Literature DB >> 15790018

[Treatment of atopic dermatitis: practical approach].

G Rossetti1, E Laffitte, P A Eigenmann, J Lübbe, D Hohl, M F Hofer.   

Abstract

Atopic dermatitis (AD) is a chronic disease frequent in childhood. The treatment is based on regular moisturizing of the skin, information to the parents on the chronic course with recurrent flares, topical anti-infectious therapy for superinfections and colonization of the skin by staphylococcus aureus, and topical steroids. The immuno-modulatory macrolides (tacrolimus and pimecrolimus) represent a new alternative to topical steroids. These molecules are well tolerated, but theirs effects on the long-term are unknown. A food allergy may be responsible for a AD flare in up to a third of the cases, but the presence of an allergy should be demonstrated before the prescription of an elimination diet. AD is often the first manifestation of atopy: the physician should be aware of the future occurence of respiratory symptoms.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15790018

Source DB:  PubMed          Journal:  Rev Med Suisse        ISSN: 1660-9379


  1 in total

1.  Effect of DHU001, a Polyherbal Formula, on Dinitrofluorobenzene-induced Contact Dermatitis (Type I allergy).

Authors:  Hyeung-Sik Lee; Byung-Chang Lee; Sae-Kwang Ku
Journal:  Toxicol Res       Date:  2010-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.